Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study
Abstract The therapeutic options for disease modification in relapsing-remitting multiple sclerosis (RRMS) have expanded remarkably in the last 15 years. Although intravenous immunoglobulins (IVIg) have shown some therapeutic effects in multiple sclerosis, reducing global supplies, restriction of tr...
Main Authors: | Srishti Gupta, Mohnish Suri, Cris S. Constantinescu |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-08-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-020-00209-0 |
Similar Items
-
Artículo de opinión: neoplasias cutáneas en el síndrome de Muir-Torre Opinion article: cutaneous neoplasms in Muir-Torre syndrome
by: RE Achenbach
Published: (2012-06-01) -
Muir-Torre Syndrome: The Importance of a Detailed Family History
by: Christopher K.H. Burris, et al.
Published: (2019-05-01) -
The role of immunohistochemistry in the Muir-Torre Syndrome
by: Cláudia Marina Puga Barbosa Oliveira, et al.
Published: (2015-06-01) -
Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome
by: Shaina P. Royer, et al.
Published: (2022-04-01) -
Classification, nosology and diagnostics of Ehlers-Danlos syndrome
by: Ben C J Hamel
Published: (2019-12-01)